語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Safety evaluation of medical devices
~
Gad, Shayne C., (1948-)
FindBook
Google Book
Amazon
博客來
Safety evaluation of medical devices
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Safety evaluation of medical devices / Shayne Cox Gad.
作者:
Gad, Shayne C.,
出版者:
New York :M. Dekker, : c2002.,
面頁冊數:
xii, 558 p. :ill. ;23 cm.
內容註:
Machine generated contents note: Preface to the Second Edition -- Preface to the First Edition -- 1 Introduction -- I. Biocompatibility -- II. Scope of Devices and the Medical Device Market -- III. History -- IV. Nonspecific Regulatory Considerations -- References -- 2 Regulatory Aspects and Strategy in Medical Device and Biomaterials Safety Evaluation -- I. Regulatory Basis -- II. Toxicity Testing: Medical Devices -- References -- 3 Road Map to Test Selections -- I. Key Concepts -- II. Conditions of Use -- III. Materials, Components, and Products -- IV. Prior Knowledge -- V. Types and Uses of Tests -- References -- 4 What to Test: Sampling and Sample Preparation -- I. Sampling -- II. Randomization -- III. Sample Preparation -- IV. Reference Materials -- V. Conclusion -- References -- 5 Cytotoxicity Testing -- I. Background -- II. Cytotoxicity Assays -- III. Conclusion -- References -- 6 Blood Compatibility -- I. Introduction -- II. Standard Tests -- III. Conclusion -- References -- 7 Irritation and Pyrogenicity -- I. Dermal Irritation -- II. Ocular Irritation Testing -- III. Other Nonparenteral Route Irritation Tests -- IV. Parenteral Irritation/Tolerance -- V. Parenteral Routes -- VI. Intracutaneous Irritation -- VII. Problems in Testing (and Their Resolutions) -- References -- 8 Immunotoxicology -- I. Overview of the Immune System -- II. Evaluation of the Immune System -- III. Local Lymph Node Assay -- IV. Approaches -- V. Problems and Future Directions -- References -- 9 Implantation Biology and Studies -- I. USP Implantation Test -- II. British Pharmacopoeia -- III. ISO 10993 Implantation Test -- IV. Test Method for Implantation in Subcutaneous Tissue -- V. Test Method for Implantation in Muscle -- VI. Test Method for Implantation in Bone -- VII. Control Materials -- VIII. Long-Term Implant Studies -- IX. Considerations -- References -- 10 Genotoxicity -- I. DNA Structure -- II. Cytogenetics -- III. In Vitro Cytogenetic Assays -- IV. In Vivo Cytogenetic Assays -- V. Sister Chromatid Exchange Assays -- References -- 11 Subchronic and Chronic Toxicity and Reproductive and -- Developmental Toxicity -- I. Objectives -- II. Regulatory Considerations -- III. Parameters to Measure -- IV. Histopathology -- V. Study Interpretation and Reporting -- VI. Reproductive and Developmental Toxicity -- References -- 12 Carcinogenicity -- I. Animal Model -- II. Dose Selection -- III. Interpretation of Results -- References -- 13 Sterility, Sterilization, and Heavy Metals -- I. Sterility -- II. Heavy Metals -- References -- 14 Combination Devices -- I. Combination Products -- II. Device Programs that CDER and CBRH Will Administer -- References -- 15 Clinical Studies for Medical Devices -- I. Design Considerations -- II. Epidemiology -- III. Conclusion -- References -- 16 Special Studies -- I. Cardiovascular Devices and Prostheses -- II. Tampons -- III. Contact Lenses and Their Solutions -- IV. Specific Tests -- V. Twenty-One-Day Eye Irritation Study in Rabbits -- VI. Systemic Injection Test -- VII. Production of Toxic Shock Syndrome Toxin-l (TSST-1) -- VIII. In Vitro Evaluation of the Effects of Potential Tampon -- Materials on pH and Growth of Vaginal Microflora -- IX. Inflammatory Responses to Biomaterials -- References -- 17 Case Histories and Problem Resolution -- I. Phthalate and Other Residuals Leaching from Devices -- II. Dalkon Shield -- III. Talc on Gloves and Condoms -- IV. Toxic Shock Syndrome -- V. Latex Allergy -- VI. Silicones in Devices -- VII. Problem Solving -- VIII. Risk Assessments -- IX. Conclusion -- References -- Appendix A: Selected Regulatory and Toxicological Acronyms -- and Abbreviations -- Appendix B: Contract Testing Laboratories -- Appendix C: Notable Regulatory Internet Addresses -- Appendix D: Non-U.S. Medical Device Regulators -- Index.
標題:
Biocompatibility - Testing. -
電子資源:
http://www.taebcnetbase.com/ejournals/books/book_km.asp?id=2090Click here for the electronic version
ISBN:
082470617X (alk. paper)
Safety evaluation of medical devices
Gad, Shayne C.,1948-
Safety evaluation of medical devices
[electronic resource] /Shayne Cox Gad. - 2nd ed., rev. and expanded. - New York :M. Dekker,c2002. - xii, 558 p. :ill. ;23 cm.
Includes bibliographical references and index.
Machine generated contents note: Preface to the Second Edition -- Preface to the First Edition -- 1 Introduction -- I. Biocompatibility -- II. Scope of Devices and the Medical Device Market -- III. History -- IV. Nonspecific Regulatory Considerations -- References -- 2 Regulatory Aspects and Strategy in Medical Device and Biomaterials Safety Evaluation -- I. Regulatory Basis -- II. Toxicity Testing: Medical Devices -- References -- 3 Road Map to Test Selections -- I. Key Concepts -- II. Conditions of Use -- III. Materials, Components, and Products -- IV. Prior Knowledge -- V. Types and Uses of Tests -- References -- 4 What to Test: Sampling and Sample Preparation -- I. Sampling -- II. Randomization -- III. Sample Preparation -- IV. Reference Materials -- V. Conclusion -- References -- 5 Cytotoxicity Testing -- I. Background -- II. Cytotoxicity Assays -- III. Conclusion -- References -- 6 Blood Compatibility -- I. Introduction -- II. Standard Tests -- III. Conclusion -- References -- 7 Irritation and Pyrogenicity -- I. Dermal Irritation -- II. Ocular Irritation Testing -- III. Other Nonparenteral Route Irritation Tests -- IV. Parenteral Irritation/Tolerance -- V. Parenteral Routes -- VI. Intracutaneous Irritation -- VII. Problems in Testing (and Their Resolutions) -- References -- 8 Immunotoxicology -- I. Overview of the Immune System -- II. Evaluation of the Immune System -- III. Local Lymph Node Assay -- IV. Approaches -- V. Problems and Future Directions -- References -- 9 Implantation Biology and Studies -- I. USP Implantation Test -- II. British Pharmacopoeia -- III. ISO 10993 Implantation Test -- IV. Test Method for Implantation in Subcutaneous Tissue -- V. Test Method for Implantation in Muscle -- VI. Test Method for Implantation in Bone -- VII. Control Materials -- VIII. Long-Term Implant Studies -- IX. Considerations -- References -- 10 Genotoxicity -- I. DNA Structure -- II. Cytogenetics -- III. In Vitro Cytogenetic Assays -- IV. In Vivo Cytogenetic Assays -- V. Sister Chromatid Exchange Assays -- References -- 11 Subchronic and Chronic Toxicity and Reproductive and -- Developmental Toxicity -- I. Objectives -- II. Regulatory Considerations -- III. Parameters to Measure -- IV. Histopathology -- V. Study Interpretation and Reporting -- VI. Reproductive and Developmental Toxicity -- References -- 12 Carcinogenicity -- I. Animal Model -- II. Dose Selection -- III. Interpretation of Results -- References -- 13 Sterility, Sterilization, and Heavy Metals -- I. Sterility -- II. Heavy Metals -- References -- 14 Combination Devices -- I. Combination Products -- II. Device Programs that CDER and CBRH Will Administer -- References -- 15 Clinical Studies for Medical Devices -- I. Design Considerations -- II. Epidemiology -- III. Conclusion -- References -- 16 Special Studies -- I. Cardiovascular Devices and Prostheses -- II. Tampons -- III. Contact Lenses and Their Solutions -- IV. Specific Tests -- V. Twenty-One-Day Eye Irritation Study in Rabbits -- VI. Systemic Injection Test -- VII. Production of Toxic Shock Syndrome Toxin-l (TSST-1) -- VIII. In Vitro Evaluation of the Effects of Potential Tampon -- Materials on pH and Growth of Vaginal Microflora -- IX. Inflammatory Responses to Biomaterials -- References -- 17 Case Histories and Problem Resolution -- I. Phthalate and Other Residuals Leaching from Devices -- II. Dalkon Shield -- III. Talc on Gloves and Condoms -- IV. Toxic Shock Syndrome -- V. Latex Allergy -- VI. Silicones in Devices -- VII. Problem Solving -- VIII. Risk Assessments -- IX. Conclusion -- References -- Appendix A: Selected Regulatory and Toxicological Acronyms -- and Abbreviations -- Appendix B: Contract Testing Laboratories -- Appendix C: Notable Regulatory Internet Addresses -- Appendix D: Non-U.S. Medical Device Regulators -- Index.
ISBN: 082470617X (alk. paper)
LCCN: 2001058401Subjects--Topical Terms:
915737
Biocompatibility
--Testing.
LC Class. No.: R857.M3 / G33 2002
Dewey Class. No.: 681/.761/0287
National Library of Medicine Call No.: QT 37 / G123s 2002
Safety evaluation of medical devices
LDR
:04978cam a2200313 a 45
001
777819
005
20081028
006
m d
007
cr cn ---ancau
008
081028s2002 nyua sb 001 0 eng
010
$a
2001058401
020
$a
082470617X (alk. paper)
035
$a
(DNLM)101134533
035
$a
12619575
040
$a
DNLM/DLC
$c
DLC
$d
DLC
042
$a
pcc
050
0 0
$a
R857.M3
$b
G33 2002
060
1 0
$a
QT 37
$b
G123s 2002
082
0 0
$a
681/.761/0287
$2
21
100
$a
Gad, Shayne C.,
$d
1948-
$3
813897
245
1 0
$a
Safety evaluation of medical devices
$h
[electronic resource] /
$c
Shayne Cox Gad.
250
$a
2nd ed., rev. and expanded.
260
$a
New York :
$c
c2002.
$b
M. Dekker,
300
$a
xii, 558 p. :
$b
ill. ;
$c
23 cm.
504
$a
Includes bibliographical references and index.
505
8
$a
Machine generated contents note: Preface to the Second Edition -- Preface to the First Edition -- 1 Introduction -- I. Biocompatibility -- II. Scope of Devices and the Medical Device Market -- III. History -- IV. Nonspecific Regulatory Considerations -- References -- 2 Regulatory Aspects and Strategy in Medical Device and Biomaterials Safety Evaluation -- I. Regulatory Basis -- II. Toxicity Testing: Medical Devices -- References -- 3 Road Map to Test Selections -- I. Key Concepts -- II. Conditions of Use -- III. Materials, Components, and Products -- IV. Prior Knowledge -- V. Types and Uses of Tests -- References -- 4 What to Test: Sampling and Sample Preparation -- I. Sampling -- II. Randomization -- III. Sample Preparation -- IV. Reference Materials -- V. Conclusion -- References -- 5 Cytotoxicity Testing -- I. Background -- II. Cytotoxicity Assays -- III. Conclusion -- References -- 6 Blood Compatibility -- I. Introduction -- II. Standard Tests -- III. Conclusion -- References -- 7 Irritation and Pyrogenicity -- I. Dermal Irritation -- II. Ocular Irritation Testing -- III. Other Nonparenteral Route Irritation Tests -- IV. Parenteral Irritation/Tolerance -- V. Parenteral Routes -- VI. Intracutaneous Irritation -- VII. Problems in Testing (and Their Resolutions) -- References -- 8 Immunotoxicology -- I. Overview of the Immune System -- II. Evaluation of the Immune System -- III. Local Lymph Node Assay -- IV. Approaches -- V. Problems and Future Directions -- References -- 9 Implantation Biology and Studies -- I. USP Implantation Test -- II. British Pharmacopoeia -- III. ISO 10993 Implantation Test -- IV. Test Method for Implantation in Subcutaneous Tissue -- V. Test Method for Implantation in Muscle -- VI. Test Method for Implantation in Bone -- VII. Control Materials -- VIII. Long-Term Implant Studies -- IX. Considerations -- References -- 10 Genotoxicity -- I. DNA Structure -- II. Cytogenetics -- III. In Vitro Cytogenetic Assays -- IV. In Vivo Cytogenetic Assays -- V. Sister Chromatid Exchange Assays -- References -- 11 Subchronic and Chronic Toxicity and Reproductive and -- Developmental Toxicity -- I. Objectives -- II. Regulatory Considerations -- III. Parameters to Measure -- IV. Histopathology -- V. Study Interpretation and Reporting -- VI. Reproductive and Developmental Toxicity -- References -- 12 Carcinogenicity -- I. Animal Model -- II. Dose Selection -- III. Interpretation of Results -- References -- 13 Sterility, Sterilization, and Heavy Metals -- I. Sterility -- II. Heavy Metals -- References -- 14 Combination Devices -- I. Combination Products -- II. Device Programs that CDER and CBRH Will Administer -- References -- 15 Clinical Studies for Medical Devices -- I. Design Considerations -- II. Epidemiology -- III. Conclusion -- References -- 16 Special Studies -- I. Cardiovascular Devices and Prostheses -- II. Tampons -- III. Contact Lenses and Their Solutions -- IV. Specific Tests -- V. Twenty-One-Day Eye Irritation Study in Rabbits -- VI. Systemic Injection Test -- VII. Production of Toxic Shock Syndrome Toxin-l (TSST-1) -- VIII. In Vitro Evaluation of the Effects of Potential Tampon -- Materials on pH and Growth of Vaginal Microflora -- IX. Inflammatory Responses to Biomaterials -- References -- 17 Case Histories and Problem Resolution -- I. Phthalate and Other Residuals Leaching from Devices -- II. Dalkon Shield -- III. Talc on Gloves and Condoms -- IV. Toxic Shock Syndrome -- V. Latex Allergy -- VI. Silicones in Devices -- VII. Problem Solving -- VIII. Risk Assessments -- IX. Conclusion -- References -- Appendix A: Selected Regulatory and Toxicological Acronyms -- and Abbreviations -- Appendix B: Contract Testing Laboratories -- Appendix C: Notable Regulatory Internet Addresses -- Appendix D: Non-U.S. Medical Device Regulators -- Index.
650
$a
Biocompatibility
$x
Testing.
$3
915737
650
$a
Biomedical materials
$x
Testing.
$3
656158
650
$a
Biomedical materials
$x
Toxicity testing.
$3
915738
650
$a
Biocompatible Materials.
$3
702082
650
$a
Materials Testing.
$3
867607
650
$a
Equipment Failure.
$3
915739
650
$a
Equipment Safety.
$3
915740
650
$a
Toxicity Tests.
$3
773521
856
4 0
$3
CRCnetBASE
$u
http://www.taebcnetbase.com/ejournals/books/book_km.asp?id=2090
$z
Click here for the electronic version
906
$a
7
$b
cbc
$c
orignew
$d
1
$e
ocip
$f
20
$g
y-gencatlg
925
0
$a
acquire
$b
1 shelf copy
$x
policy default
955
$a
a jc00 2001-12-19 to jc15
$d
jc15 2001-12-20
$e
jc13 2001-12-20 to Dewey
$a
aa07 2001-12-21
$f
jc16 2002-10-01
$g
jc13 2002-10-02 to BCCD
985
$a
NLMCIP
$d
2001-12-19
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9054733
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入